ARTICLE | Clinical News
CER-001: Phase IIb data
January 6, 2014 8:00 AM UTC
Top-line data from the double-blind, dose-escalation, international Phase IIb CHI-SQUARE trial in 507 patients showed that once-weekly IV CER-001 for 6 weeks missed the primary endpoint of reducing to...